RxDoctor Payments Data

Stephanie Taylor

Infectious Disease · New Orleans, LANPI 1205855277

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Roche Molecular Systems, Inc. at 51.6% of the total. Reporting peaked in 2019 at $13,896 and has fallen 81.8% since, to $2,535 in 2024. Among infectious disease clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,611in general payments, 2019–2025

Across 23 payments — averaging $1070.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$13K
  • Roche Diagnostics Corporation$4K
  • Gen-probe Sales & Service, Inc.$4K
  • La Jolla Pharmaceutical Company$3K
  • GSK$690
  • Gilead$121
  • plus $115 from 1 others
$1,582,916in research payments, 2019–2025

Across 69 payments — averaging $22,941 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BD$1.2M
  • Gen-probe, Inc.$331K
  • GSK$42K
  • Roche Molecular Systems, Inc.$7K

What the payments were for

  • Consulting fees$10,56543%
  • Speaking & faculty fees$9,90840%
  • Travel & lodging$2,42910%
  • Food & beverage$1,7097%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Molecular Systems, Inc.5$12,688
Roche Diagnostics Corporation8$4,348
Gen-probe Sales & Service, Inc.3$4,113
La Jolla Pharmaceutical Company4$2,535
GSK1$690
Gilead1$121
Medical Device Business Services, Inc.1$115

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,611 in reported general payments places this provider in the 95th percentile of 105 infectious disease providers in Louisiana.

See all infectious disease providers in Louisiana →

Other infectious disease in New Orleans

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →